Sunday, April 14, 2024


Stocks Correction

Nifty Pharma under pressure: Is it time to square off your positions?

A few Indian pharma companies are already working in the specialty products business in the US, which is a very high-value market as against the traditional generic business.

All in the name of Coronavirus

Do we have a vaccine for HIV? No; Maleria? No; SARS/MERS? No; But we are not scared of them today. Why?

Latest News

Recently Popular